|
第十届中国卫生技术评估论坛
10th China Health Technology Assessment Forum
|
时间：2016.11.11-13
Time: Nov.11-13, 2016
|
地点：中国杭州
Place: Hangzhou, China
|
|
|
时间 TIME
|
内容 CONTENTS
|
|
第一天（11.11） Day One (Nov.11)
|
|
9:00-17:00
|
培训班 1：卫生技术评估
Workshop 1: HTA101
|
培训班 2：高级经济学评价
Workshop 2: Advanced economic evaluation
|
|
第二天（11.12） Day Two (Nov. 12)
|
|
8:30-9:00
|
开 幕 式 Opening Ceremony
|
|
9:00-10:30
|
英国、加拿大、美国HTA发展经验
HTA experience from developed countries (UK, Canada and USA)
|
Kalipso Chalkidou:HTA在福利包设计和报销决策的应用
Kalipso Chalkidou: HTA To Inform Benefits Package Design And Reimbursement
Decisions: The Experience of NICE And Beyond
|
Don Juzwishin：加拿大HTA：新挑战与新机遇
Don Juzwishin: HTA in Canada - New Challenges and New Opportunities
|
Clifford Goodman：美国HTA：强调价值
Clifford Goodman：HTA in the US - Emphasis on Value
|
|
10:30-11:00
|
茶 歇 Tea break
|
|
11:00-12:00
|
中国HTA政策需求
The policy needs for HTA in China
|
|
12:00-13:30
|
午 餐 Lunch
|
|
13:30-15:00
|
中国HTA实践进展
HTA practice in China
|
赵琨：中国卫生技术评估进展和决策转化案例
Zhao Kun：HTA Progress and Knowledge Translation Case in China
|
李幼平：用HTA结果帮助提高卒中诊治效果的探索
Li Youping: Use the HTA Results to
Help Improve the Effect of Diagnosis and Treatment of Stroke
|
陈英耀：二代测序技术检测唐氏综合征的技术评估
Chen Yingyao: Technology Assessment of Second
Generation Sequencing Technology to Detect Down's Syndrome
|
董恒进：卡迪夫模型及在糖尿病干预评估中的应用
Dong Hengjin: Cardiff Model and Its Application
in Evaluating Diabetes Interventions
|
|
15:00-15:20
|
茶 歇 Tea break
|
|
15:20-16:50
|
药品评价与政策
Pharmaceutical evaluation and policy
|
精准医疗
Precision medicine |
新技术HTA
HTA for Emerging technology
|
Ellen't Hoen: 知识产权与高药价
Ellen't Hoen: Intellectual Property and High
Drug Prices
|
于浩: 美国准入资格许可的法律回顾
Yu Hao: Certificate-of-Need Laws in the U.S.: A
Review
|
胡泽斌: 干细胞治疗技术安全性评估
Hu Zebin:Safety Assessment of Stem Cell Therapy
Technology
|
胡善联:丙型肝炎病毒的消除:PE评价能做什么？
Hu Shanlian: Elimination of Hepatitis C
Virus: What PE Evaluation Can Do? |
李斌: 磁共振影像设备工程性能服务评价
Li bin:
Magnetic Resonance Imaging Equipment engineering service performance
evaluation |
王立生: 大规模间充质干细胞培养技术评估
Wang Lisheng: Large-scale Mesenchymal Stem Cell Culture Techniques
Assessment |
施李正: 高价药成本分担解决方案的经验介绍
Shi Lizheng:Practical Solutions When Facing Cost
Sharing for High-Priced Drugs: US Experience
|
国家卫生计生委：已定 |
吴朝晖: 新技术评估的体会和思考 Wu Chaohui:The Experience and Thinking of New Emerging Technology
Assessment
|
|
17:00-18:15
|
大会发言1
Oral
|
大会发言2
Oral
|
大会发言3
Oral
|
|
1、周尚成 某特异性免疫滴剂治疗过敏性哮喘药物经济学评价
|
1、杨春松 中国抽动障碍西药治疗随机对照试验证据现状与趋势分析
|
1、何达 上海市CT和MRI配置现状分析
|
|
2、程晓庆 儿童接种甲接型肝炎疫苗的卫生经济学分析:系统综述
|
2、王建明 线性探针法在耐多药结核病快速诊断中的应用价值研究
|
2、朱立国 县级区域内慢性乙肝患者规范抗病毒治疗的筹资模式评估
|
|
3、贺小宁 钆塞酸二钠用于肝细胞癌患者初始放射影像诊断的卫生经济学评估
|
3、李顺平 我国乳腺癌患者健康效用值的比较研究
|
3、耿劲松 新技术纳入医保报销范围的多准则决策框架研究
|
|
4、谢玉 经济落后地区宫颈癌不同筛查方案的卫生经济学评价
|
4、邵海妍 某市中-盖结核病防治项目的卫生经济学评价
|
4、周萍 卫生技术评估在政策决策中的应用 —基于典型发达国家的经验与启示
|
|
5、刘柳 乳腺癌患者术后辅助化疗方案成本效用分析的系统综述
|
5、杨月华 宫铜300与其他类宫腔形支架宫内节育器脱落情况比较的meta分析
|
5、张研 中部地区农村居民县级医院不合理入院现状评估
|
|
6、张璐莹 中国妊娠糖尿病筛查和干预的成本效果分析
|
6、唐文熙 大手术中主动保温系统和传统被动保温措施的经济学评价方案：基于临床随机对照试验
|
6、王继伟 癌症生存者多焦点住宿性社会心理干预研究
|
|
第三天（11.13） Day Three (Nov.13)
|
|
8:30-10:00
|
政策转化
Policy Translation
|
服务体系HTA
HTA in health care system
|
循证医学
Evidence-based medicine
|
|
张勘：政策转化 Zhang Kan:Policy Translation
|
薛迪：HTA与临床路径
Xue Di: HTA with Clinical Pathway |
张博恒：循证医学实践和挑战 Zhang Boheng:Evidence-based Medicine: Practice and Challenge
|
|
代涛 Dai Tao
|
王桢：完善药品集中采购机制的探索
Wang Zhen: Pilot of drug central procuring
mechanism |
郑英杰：meta分析方法与应用 Zheng Yingjie: Meta Analysis Method and Application
|
|
应晓华 Ying Xiaohua
|
倪沪平：三医联动下的医保政策思维
Ni Huping: Strategic plan of medical insurance policy in the context
of integrated endovor of medical service, medical insurance and medicine |
万宏伟：循证护理－科研选题与实践
Wan Hongwei: Evidence-based Nursing——Scientific Research Topic
Selection and the Practice |
|
10:00-10:20
|
茶 歇 Tea break
|
|
10:20-11:50
|
医疗保险
Medical insurance
|
医院HTA
Hospital-based HTA
|
设备HTA
HTA for Equipment |
李秀娟：卫生技术评估与医疗保险之上海实践
Li Xiujuan: HTA with Medical Insurance:ShangHai Experience |
杨海：基于医院的卫生技术评估 Yang Hai:Hospital-based HTA
|
宣建伟：医疗大数据库的建立及在循证医学中的应用 XuanJianWei:The Establishment of Big Data
and its Application in Evidence-based Medicine
|
徐玮：建设健康中国医保的责任与担当
Xu
Wei: The Responsibility of Medical Insurance in Healthy China Construction |
黄进：倒刺线的临床应用评价 Huang Jin:Evaluation of Agnail Line Clinical Application
|
谷成明：大数据在精准医疗和医保中的应用
Gu Chengming: The
Application of Big Data in Precision Medicine and Medical Insurance |
于保荣：卫生技术评估在医疗保险体系中的应用
Yu Baorong:HTA in the
Application of Medical Insurance System |
潘柏申：临床检验项目收费标准评价与优化研究
Pan
Bosheng:Clinical Laboratory Test items charge standard evaluation and
optimization research
|
陶立波：大数据对于医药经济学评估的意义
Tao Libo: The
Meaning of Big Data for medical economics evaluation |
|
12:00-12:30
|
闭 幕 式 Closing ceremony
|
|
雷海潮：健康影响评价评估制度探讨 Lei Haichao: Health
impact Assessment and Evaluation System
|
|
大会总结 Meeting Summary
|
